Literature DB >> 20635286

Men in methadone maintenance versus psychosocial outpatient treatment: differences in sexual risk behaviors and intervention effectiveness from a multisite HIV prevention intervention trial.

Donald A Calsyn1, Aimee N C Campbell, Paul Crits-Christoph, Suzanne R Doyle, Susan Tross, Mary A Hatch-Maillette, Raul Mandler.   

Abstract

The effectiveness of the Real Men Are Safe (REMAS) HIV prevention intervention was examined as a function of treatment program modality. REMAS was associated with significantly larger decreases in unprotected sexual occasions than an HIV education control condition in both treatment modalities. REMAS had superior effectiveness for reducing unprotected sexual occasions in the psychosocial outpatient compared to methadone. At the 6-month follow-up, the adjusted mean change for REMAS completers in psychosocial outpatient (M=6.4, d=0.38) was greater than for REMAS completers in methadone programs (M=2.3, d=0.25). Reasons for why REMAS appears to be especially effective in psychosocial outpatient programs are explored.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20635286      PMCID: PMC2906815          DOI: 10.1080/10550887.2010.489451

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  28 in total

1.  Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs.

Authors:  M L Prendergast; D Urada; D Podus
Journal:  J Consult Clin Psychol       Date:  2001-06

2.  A study of the sexuality of opiate addicts.

Authors:  A Pacheco Palha; M Esteves
Journal:  J Sex Marital Ther       Date:  2002 Oct-Dec

3.  Delivery of HIV risk-reduction services in drug treatment programs.

Authors:  C E Grella; R M Etheridge; V Joshi; M D Anglin
Journal:  J Subst Abuse Treat       Date:  2000-10

4.  A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States.

Authors:  Salaam Semaan; Don C Des Jarlais; Ellen Sogolow; Wayne D Johnson; Larry V Hedges; Gilbert Ramirez; Stephen A Flores; Lisa Norman; Michael D Sweat; Richard Needle
Journal:  J Acquir Immune Defic Syndr       Date:  2002-07-01       Impact factor: 3.731

Review 5.  Drug abuse treatment as an HIV prevention strategy: a review.

Authors:  J L Sorensen; A L Copeland
Journal:  Drug Alcohol Depend       Date:  2000-04-01       Impact factor: 4.492

6.  Reliability of self-reports about sexual risk behavior for HIV among homeless men with severe mental illness.

Authors:  N Sohler; P W Colson; H F Meyer-Bahlburg; E Susser
Journal:  Psychiatr Serv       Date:  2000-06       Impact factor: 3.084

7.  Effectiveness of communication and relationship skills training for men in substance abuse treatment.

Authors:  N G Bartholomew; M L Hiller; K Knight; D C Nucatola; D D Simpson
Journal:  J Subst Abuse Treat       Date:  2000-04

8.  Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team.

Authors:  D S Metzger; B Koblin; C Turner; H Navaline; F Valenti; S Holte; M Gross; A Sheon; H Miller; P Cooley; G R Seage
Journal:  Am J Epidemiol       Date:  2000-07-15       Impact factor: 4.897

9.  Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team.

Authors:  M Gross; S E Holte; M Marmor; A Mwatha; B A Koblin; K H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2000-08-01       Impact factor: 3.731

10.  Drugs and sexual effects: role of drug type and gender.

Authors:  Richard A Rawson; Arnold Washton; Catherine P Domier; Chris Reiber
Journal:  J Subst Abuse Treat       Date:  2002-03
View more
  1 in total

1.  Predictors and moderators of outcomes of HIV/STD sex risk reduction interventions in substance abuse treatment programs: a pooled analysis of two randomized controlled trials.

Authors:  Paul Crits-Christoph; Robert Gallop; Jaclyn S Sadicario; Hannah M Markell; Donald A Calsyn; Wan Tang; Hua He; Xin Tu; George Woody
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-01-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.